Skip to main content
Premium Trial:

Request an Annual Quote

MGI Receives China FDA Registration for Sequencers

NEW YORK (GenomeWeb) – MGI, a subsidiary of BGI, has received the medical device registration certificate from the China Food and Drug Administration for its two next-generation sequencers, MGISEQ-2000 and MGISEQ-200. The certification enables healthcare organizations to use the instruments for clinical purposes.

According to the company, the MGISEQ-2000 instrument has two different flow cells that enable users to combine different operating modes and can generate 1,080 gigabases of sequencing data within 48 hours. MGISEQ-200 can produce 60 gigabases of data in less than 48 hours.

MGI launched the instruments last year.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.